On earnings calls this week, several technology giants pointed to DeepSeek's software having "clever tricks," while also raising questions about the security and effectiveness of the Chinese-based ...

DeepSeek spooked US markets on news that the model’s developers were able to produce a worthy competitor to American AI firms ...

As the AI ascendency moves further into the new year, new themes, surprises, breakthroughs, and perhaps market-moving ...

Wall Street shares were slightly higher on Thursday, as investors cheered earnings from Meta , but were disappointed by ...

We recently published a list of 10 Unstoppable Tech Stocks to Buy Right Now. In this article, we are going to take a look at ...

We recently published a list of 10 AI Stocks Analysts Are Focusing On These Days. In this article, we are going to take a look at where Amazon.com, Inc.

Apple stock has held up this week, while Nvidia has fallen. The iPhone maker is heading into earnings holding the title of most valuable company. This has been an incredibly busy week for the stock ...

Key tech stocks were a mixed bag in early trading Thursday after executives at Meta and Microsoft said they plan to keep ...

Apple’s report Thursday afternoon is the latest in a busy week for earnings and will provide a test for the iPhone maker’s ...

Energy demands from big tech, including for AI, has elected officials giving an old power source a second look. Story from @CalMatters.org.

It recently reported its fiscal Q2 2025 earnings. The stock tanked by 4% but started recovering immediately and is now down by 2% after earnings. Let’s take a look into what happened.

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...